
Discover the EPA and DHA dosages studied for supporting mobility, inflammation regulation and joint health in dogs.
Published in
Omega-3Joint disorders are common, particularly in ageing dogs, large breeds and dogs with a genetic predisposition. The need for well-tolerated nutritional support for these painful conditions has prompted research into the effects of Omega-3s. But what dosage has been studied for supporting a dog's mobility and joint comfort? Here is what veterinary clinical studies report.
Joint disorders particularly affect older dogs, large breeds and dogs with a genetic predisposition. To help manage pain and preserve mobility, veterinary research has focused on Omega-3 fatty acids, notably EPA and DHA, which are involved in regulating inflammatory processes.
Dogs do not produce sufficient amounts of these two fatty acids themselves. Dietary sources include fatty fish, New Zealand green-lipped mussels or marine microalgae.
EPA is a fatty acid that plays a key role in regulating inflammation. It can influence the production of inflammatory mediators involved in joint pain and inflammation, including prostaglandins and leukotrienes.
Many of these mediators are produced from another fatty acid, arachidonic acid. EPA competes with arachidonic acid and supports the production of less inflammatory mediators.
It also supports the production of resolvins, compounds involved in the natural resolution of inflammatory processes.
DHA is incorporated into cell membranes throughout the body, including those of the brain, nervous system and immune system. It helps maintain membrane fluidity, which supports effective communication between cells.
In joint disorders, DHA also contributes to the regulation of inflammation. It may also help regulate the activity of certain enzymes involved in the degradation of joint tissues, including cartilage. It therefore plays a protective role and helps preserve joint integrity over the long term.
Discover our guide to Omega-3s
Published studies do not establish a single EPA and DHA dose suitable for every dog with arthritis. The quantities studied vary according to the animal's health, diet, the formulation used and the duration of the protocol.
The studies presented below involved dogs with diagnosed joint disorders that were monitored in a veterinary setting for a defined period. They provide an overview of the doses evaluated in clinical contexts, but do not constitute a general recommendation for every dog.
These protocols should be distinguished from maintenance nutritional intake intended for daily support. A moderate dose administered over the long term is not equivalent to a higher clinical dose given for a few weeks, as these approaches serve different purposes.
In this study, 177 dogs with osteoarthritis received food enriched with EPA and DHA for three months at different doses, up to 4 g/1,000 kcal. The groups receiving the highest doses showed a significant improvement in lameness, pain on palpation, and mobility. The reported benefit increased with the dose studied.
In this study, 74 dogs with osteoarthritis received 69 mg/kg/day of EPA and DHA for 12 weeks. The researchers reported a significant reduction in pain and joint stiffness on the visual analogue scale (VAS), along with improved owner-assessed function.
This systematic review covered 23 randomised clinical trials in dogs and cats. It reported benefits for pain, locomotion and quality of life in animals with joint disorders, particularly at intakes of 60 to 100 mg/kg/day.
Although arthritis is the most widely documented indication, clinical studies have also investigated EPA and DHA in other conditions, including allergic dermatitis, dry keratoconjunctivitis, poor coat quality, cardiovascular disease and lymphoma.
The table below summarizes the dosages studied in the scientific literature:
| Condition | Dosage studied | Minimum duration | Observed clinical effects |
|---|---|---|---|
| Osteoarthritis / Joint disorders | 60-100 mg/kg/day | 6 to 12 weeks | Reduction of pain and stiffness, improved mobility |
| Allergic dermatitis | 50-90 mg/kg/day | 8 to 10 weeks | Decrease in pruritus, erythema, secondary lesions |
| Dry keratoconjunctivitis | EPA:DHA ratio 1.5:1 | 6 months | Improvement of ocular clinical signs |
| Dull coat / Degraded coat | EPA: 16 mg/kg DHA: 10 mg/kg | 3 months | Improvement of the seborrheic index |
| Valvular disease / Chronic heart failure | EPA: 27 mg/kg DHA: 18 mg/kg | 4 to 8 weeks | Improvement of cardiac echocardiographic variables |
Even in the absence of apparent joint symptoms, a moderate Omega-3 intake can help maintain joint flexibility and support the immune system, skin and coat.
In healthy adult dogs, a daily intake of 14 mg of EPA+DHA per kilogram of body weight is recommended.
To illustrate daily intake, the following guideline is based on the dog's size:
| Weight range | Average weight | Recommended daily dosage (EPA+DHA) |
|---|---|---|
| Less than 10 kg | 7 kg | 98 mg/day |
| 10 to 20 kg | 15 kg | 210 mg/day |
| 20 to 30 kg | 30 kg | 420 mg/day |
| More than 40 kg | 45 kg | 630 mg/day |
These intakes can be provided through an enriched diet or a supplement containing a quality-controlled source of Omega-3s, such as green-lipped mussel oil or algae oil, that is well tolerated over the long term. These sources support normal inflammation-regulation mechanisms and healthy ageing.
Veterinary studies suggest that EPA and DHA may support joint function in dogs. However, the dosage must be interpreted according to the context in which it is used.
Formulated with New Zealand green-lipped mussel oil and marine algae oil, PERNIXOL® provides a concentrated source of EPA and DHA in an easy-to-administer liquid form. It can form part of a regular nutritional support routine but does not replace veterinary care.
Discover PERNIXOL®
This article was written by the R&D team at Laboratoire Sensilia, experts in animal nutrition.
Sensilia Laboratory is a French, family-owned and independent laboratory based in Gironde, France. Since 2019, we have been researching and manufacturing healthy, innovative wellness products.